A novel kinase activity associated with Nef derived from neurovirulent Simian immunodeficiency virus

Virology

Volumn 251, Issue 1, 1998, Pages 165-175

  Barber, Sheila A ^a   Flaherty, Maureen T ^a   Plafker, Scott M ^b   Clements, Janice E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEF PROTEIN; PHOSPHOTRANSFERASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DEMENTIA; ENCEPHALITIS; ENZYME ACTIVITY; HUMAN IMMUNODEFICIENCY VIRUS; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS PATHOGENESIS;

HUMAN IMMUNODEFICIENCY VIRUS; MACACA MULATTA; RNA VIRUSES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0032506109     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9408     Document Type: Article

References (82)

1. Aiken C. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. J. Virol. 71:1997;5871-5877.
2. Aiken C., Konner J., Landau N. R., Lenburg M. E., Trono D. Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell. 76:1994;853-864.
3. Aiken C., Trono D. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J. Virol. 69:1995;5048-5056.
4. Anderson M. G., Hauer D., Sharma D. P., Joag S. V., Narayan O., Zink M. C., Clements J. E. Analysis of envelope changes acquired by SIVmac239 during neuroadaption in rhesus macaques. Virology. 195:1993;616-626.
5. Bandres J. C., Luria S., Ratner L. Regulation of human immunodeficiency virus Nef protein by phosphorylation. Virology. 201:1994;157-161.
6. Baur A. S., Sass G., Laffert B., Willbold D., Cheng-Meyer C., Peterlin B. M. The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase. Immunity. 6:1997;283-291.
7. Benson R. E., Sanfridson A., Ottinger J. S., Doyle C., Cullen B. R. Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection. J. Exp. Med. 177:1993;1561-1566.
8. Bhatnagar R. S., Gordon J. I. Understanding covalent modifications of proteins by lipids: where cell biology and biophysics mingle. Trends Cell Biol. 7:1997;14-18.
9. Bodeus M., Marie-Cardine A., Bougeret B., Ramos-Morales F., Benarous R. In vitro binding and phosphorylation of human immunodeficiency virus type 1 Nef protein by serine/threonine protein kinase. J. Gen. Virol. 76:1995;1337-1344.
10. Boyle, W. J. van der Geer, P. Hunter, T. 1991, Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin layer cellulose plates, In, Methods in Enzymology, 201, 110, 152, Academic Press, New York.
11. Briggs S. D., Sharkey M., Stevenson M., Smithgall T. E. SH3-mediated Hck tyrosine kinase activation and fibroblast transformation by the Nef protein of HIV-1. J. Biol. Chem. 272:1997;17899-17902.
12. Bukovsky A. A., Dorfman T., Weimann A., Gottlinger H. G. Nef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease. J. Virol. 71:1997;1013-1018.
13. Cheng-Mayer C., Weiss C., Seto D., Levy J. A. Isolates of HIV-1 from brain may constitute a special group of AIDS viruses. Proc. Natl. Acad. Sci. USA. 86:1989;8575-8579.
14. Chowers M. Y., Pandori M. W., Spina C. A., Richman D. D., Guatelli J. C. The growth advantage conferred by HIV-1 nef is determined at the level of viral DNA formation and is independent of CD4 downregulation. Virology. 212:1995;451-457.
15. Chowers M. Y., Spina C. A., Kwoh T. J., Fitch N. J. S., Richman D. D., Guatelli J. C. Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. J. Virol. 68:1994;2906-2914.
16. Clabough D. L., Gebhard D., Flaherty M. T., Whetter L. E., Perry S. T., Coggins L., Fuller F. J. Immune-mediated thrombocytopenia in horses infected with equine infectious anemia virus. J. Virol. 65:1991;6242-6251.
17. Coates K., Cooke S. J., Mann D. A., Harris M. P. G. Protein kinase C-mediated phosphorylation of HIV-1 Nef in human cell lines. J. Biol. Chem. 272:1997;12289-12294.
18. Coates K., Harries M. The human immunodeficiency virus type 1 Nef protein functions as a protein kinase C substrate in vitro. J. Gen. Virol. 76:1995;837-844.
19. Collette Y., Dutartre H., Benziane A., Ramos-Morales F., Benarous R., Harris M., Olive D. Physical and functional interaction of Nef with Lck. J. Biol. Chem. 271:1995;6333-6341.
20. Daniel M. D., Kirchhoff F., Czajak C., Sehgal P. K., Desrosiers R. C. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science. 258:1992;1938-1941.
21. De S. K., Marsh J. W. HIV-1 Nef inhibits a common pathway in NIH-3T3 cells. J. Biol. Chem. 269:1994;6656-6660.
22. Eiseman E., Bolen J. B. src-related tyrosine protein kinases as signaling components in hematopoietic cells. Cancer Cells. 2:1990;303-310.
23. Flaherty M. T., Barber S. A., Clements J. E. Neurovirulent simian immunodeficiency virus incorporates a Nef-associated kinase into virions. AIDS Res. Hum. Retrovirus. 14:1997;163-170.
24. Flaherty M. T., Hauer D. A., Mankowski J. L., Zink M. C., Clements J. E. Molecular and biological characterization of a neurovirulent molecular clone of SIV. J. Virol. 71:1997;5790-5798.
25. Foti M., Mangasarian A., Piguet V., Lew D. P., Krause K.-H., Trono D., Carpentier J.-L. Nef-mediated clathrin-coated pit formation. J. Cell Biol. 139:1997;37-47.
26. Franchini G., Robert-Guroff M., Ghrayeb J., Chang N. T., Wong-Staal F. Cytoplasmic localization of the HTLV-III 3′ orf protein in cutlured T cells. Virology. 155:1986;593-599.
27. Gabuzda D. H., Ho D. D., de la Monte S. M., Hirsch M. S., Rota T. R., Sobel R. A. Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS. Ann. Neurol. 20:1986;289-295.
28. Gartner S., Markovitz P., Markovitz D. M., Kaplan M. H., Gallo R. C., Popovic M. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science. 233:1986;215-219.
29. Graziani A., Galimi F., Medico E., Cottone E., Gramaglia D., Boccaccio C., Comoglio P. M. The HIV-1 Nef protein interferes with phosphatidylinositol 3-kinase activation. J. Biol. Chem. 271:1996;6590-6593.
30. Greenway A., Azad A., Mills J., McPhee D. Human immunodeficiency virus type 1 Nef binds directly to Lck and Mitogen-activated protein kinase, inhibiting kinase activity. J. Virol. 70:1996;6701-6708.
31. Greenway A. L., Azad A., McPhee D. A. Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines. J. Virol. 1995;1842-1850.
32. Guy B., Kieny M. P., Riviere Y., LePeuck C., Dott K., Girard M., Montagnier L., Lecocq J. P. HIV F/3′ orf encodes a phosphorylated GTP-binding protein resemblying an oncogene product. Nature. 330:1987;266-269.
33. Guy B., Riviere Y., Dott K., Regnault A., Kieny M. P. Mutational analysis of the HIV nef protein. Virology. 176:1990;413-425.
34. Hardie G., Hanks S. The protein kinase. Hardie G., Hanks S. Facts Book: Protein-Serine Kinases. 1995;Academic Press, San Diego.
35. Harris M. P. G., Neil J. C. Myristoylation-dependent binding of HIV-1 nef to CD4. J. Mol. Biol. 241:1994;136-142.
36. He J., DECastro C. M., Vandenbark G. R., Busciglio J., Gabuzda D. Astrocyte apoptosis induced by HIV-1 transactivation of the c-kit. Proc. Natl. Acad. Sci. USA. 94:1997;3954-3959.
37. Iafrate A. J., Bronson S., Skowronski J. Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling. EMBO. 16:1997;673-684.
38. Jamieson B. D., Aldrovandi G. M., Planelles V., Jowett J. B. M., Gao L., Bloch L. M., Chen I. S. Y., Zack J. A. Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. J. Virol. 68:1994;3478-3485.
39. Jelinek T., Weber M. J. Optimization of the resolution of phosphoamino acids by one-dimensional thin-layer electrophoresis. BioTechniques. 15:1993;628-629.
40. Kaminchik J., Bashan N., Itach A., Sarver N., Gorecki M., Panet A. Genetic characterization of human immunodeficiency virus type 1 nef gene products translated in vitro and expressed in mammalian cells. J. Virol. 65:1991;583-588.
41. Kaminchik J., Bashin N., Pinchaasi D., Amit B., Sarver N., Johnston M. I., Fischer M., Yavin Z., Gorecki M., Panet A. Expression and biochemical characterization of human immunodeficiency virus type 1nef. J. Virol. 64:1990;3447-3454.
42. Kestler H. W., Ringler D. J., Mori K., Panicali D. L., Sehgal P. D., Daniel M. D., Desrosiers R. C. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell. 65:1991;651-662.
43. Kienzle N., Bachmann M., Muller W. E. G., Muller-Lanztch N. Expression and cellular localization of the Nef protein from human immunodeficiency virus-type 1 in stably transfected B-cells. Arch. Virol. 124:1992;123-132.
44. Laemmli U. K. Cleavage of structural proteins duirng the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
45. Lang S. M., Iafrate A. J., Stahl-Hennig C., Kuhn E. M., Nisslein T., Kayp F.-J., Haupt M., Hunsmann G., Skowronski J., Kirchoff F. Association of simian immunodeficiency virus Nef with cellular serine/threonine kinases is dispensable for the development of AIDS in rhesus macaques. Nat. Med. 3:1997;860-865.
46. Le Gall S., Erdtmann L., Benichou S., Berlioz-Torrent C., Liu L., Benarous R., Heard J.-M., Schwartz O. Nef interacts with the u subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity. 8:1998;483-495.
47. Letvin N. L., King N. W. Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. Acquir. Immune Defic. Syndr. 3:1990;1023-1040.
48. Luo T., Douglas J. L., Livingston R. L., Garcia J. V. Infectivity enhancement by HIV-1 Nef is dependent on the pathway of virus entry: Implications for HIV-based gene transfer systems. Virology. 241:1998;224-233.
49. Luo T., Downing J. R., Garcia J. V. Induction of phosphorylation of human immunodeficiency virus type 1 Nef and enhancement of CD4 downregulation by phorbol myristate acetate. J. Virol. 71:1997;2535-2539.
50. Luo T., Garcia J. V. The association of Nef with a cellular serine/threonine kinase and its enhancement of infectivity are viral isolate dependent. J. Virol. 70:1996;6493-6496.
51. Luria S., Chambers I., Berg P. Expression of the type 1 human immunodeficiency virus Nef protein prevents antigen receptor-mediated induction of interleukin 2 mRNA. Proc. Natl. Acad. Sci. USA. 88:1991;5326-5330.
52. Mankowski J. L., Flaherty M. T., Spelman J. P., Hauer D. A., Didier P. J., Martin Amedee A., Murphey-Corb M., Kirstein L. M., Munoz A., Clements J. E., Zink M. C. Pathogenesis of simian immunodeficiency virus encephalitis: Viral determinants of neurovirulence. J. Virol. 71:1997;6055-6060.
53. Mankowski J. L., Spelman J. P., Ressetar H. G., Strandberg J. D., Laterra J., Clements J. E., Zink M. C. Neurovirulent simian immunodeficiency virus replicates productively in endothelial cells of the central nervous system in vivo and in vitro. J. Virol. 68:1994;8202-8208.
54. Miller M. D., Warmerdam M. T., Gaston I., Greene W. C., Feinberg M. B. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179:1994;101-113.
55. Moarefi I., LaFevre-Bernt M., Sicheri F., Huse M., Lee C.-H., Kuriyan J., Miller W. T. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature. 385:1997;650-653.
56. Moses A. V., Bloom F. E., Pauza C. D., Nelson J. A. Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galacytosylceramide-independent mechanism. Proc. Natl. Acad. Sci. USA. 90:1993;10474-10478.
57. Nebrada A. R., Bryan T., Segade F., Wingfield P., Vankatesan S., Santos E. Biochemical and biological comparison of HIV-1 nef and ras gene products. Virology. 183:1991;151-159.
58. Niederman T. M. J., J.Victor G., Hastings W. R., Luria S., Ratner L. Human immunodeficiency virus type 1 Nef protein inhibits NF-kB induction in human T cells. J. Virol. 66:1992;6213-6219.
59. Nunn M. F., Marsh J. W. Human immunodeficiency virus type 1 Nef associates with a member of the p21-activated kinase family. J. Virol. 70:1996;6157-6161.
60. Pandori M. W., Fitch N. J. S., Criag H. M., Richman D. D., Spina C. A., Guatelli J. C. Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein. J. Virol. 70:1996;4283-4290.
61. Power C., Kong P. A., Crawford T. O., Wessilingh S., Glass J. D., McArthur J. C., Trapp B. D. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann. Neurol. 34:1993;339-350.
62. Price R. W., Brew B., Sidtis J. J., Rosenblum M., Scheck A. C., Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science. 239:1988;586-592.
63. Price R. W., Brew B. J., Rosenblum M. The AIDS dementia complex and HIV-1 brain infection: a pathogenic model of virus-immune interaction. Immunol. Mechanism Neurol. Psychiatr. Dis. 1990;269-289.
64. Ranki A., Lagerstedt A., Ovod V., Aavik E., Krohn K. J. E. Expression kinetics and subcellular localization of HIV-1 regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell lines. Arch. Virol. 139:1994;365-378.
65. Ranki A., Nyberg M., Ovod V., Haltia M., Elovaara I., Raininko R., Haapasalo H., Krohn K. Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS. 9:1995;1001-1008.
66. Rhee S. S., Marsh J. W. Human immunodeficiency virus type 1 Nef-induced down modulation of CD4 is due to rapid internalization and degradation of surface CD4. J. Virol. 68:1994;5156-5163.
67. Richard A., Robichaud G., Lapointe R., Bourgoin S., Darveau A., Poulin L. Interference of HIV-1 Nef in the sphingomyelin transduction pathway activated by tumour necrosis factor-alpha in human glial cells. AIDS. 11:1996;F1-F7.
68. Ringler D. J., Hunt R. D., Desrosiers R. C., Daniel M. D., Chalifoux L. V., King N. W. Simian immunodeficiency virus-induced meningoencephalitis: natural history and retrospective study. Ann. Neurol. 23:1988;S101-S107.
69. Romero I. A., Teixeira A., Strosberg A. D., Cazaubon S., Couraud P.-O. The HIV-1 Nef protein inhibits extracellular signal-regulated kinase-dependent DNA synthesis in a human astrocytic cell line. J. Neurochem. 70:1998;778-785.
70. Saito Y., Sharer L. R., Epstein L. G., Michaels J., Mintz M., Louder M., Golding K., Cvetkovich T. A., Blumberg B. M. Overexpressionof nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous system. Neurology. 44:1994;474-481.
71. Sawai E. T., Baur A., Struble H., Peterlin B. M., Levy J. A., Cheng-Mayer C. Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes. Proc. Natl. Acad. Sci. USA. 91:1994;1539-1543.
72. Sawai E. T., Baur A. S., Peterlin B. M., Levy J. A., Cheng-Mayer C. A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity. J. Biol. Chem. 270:1995;15307-15314.
73. Sawai E. T., Khan I. H., Montbriand P. M., Cheng-Mayer C., Luciw P. A. Activation of PAK by HIV and SIV Nef: Importance for AIDS in rhesus macaques. Curr. Biol. 6:1996;1519-1527.
74. Schwartz O., Dautry-Varsat A., Goud B., Marechal V., Subtil A., Heard J.-M., Danos O. Human immunodeficiency virus type 1 Nef induces accumulation of CD4 in early endosomes. J. Virol. 69:1995;528-533.
75. Schwartz O., Marechal V., Le Gall S., Lemonnier F., Heard J. M. Endocytosis of major histocompatibility complex I molecules is induced by HIV-1 Nef protein. Nat. Med. 2:1996;338-342.
76. Sharma D. P., Zink M. C., Anderson M. G., Adams R., Clements J. E., Joag S. V., Narayan O. Derivation of neurotropic SIV from exclusively lymphocyte-tropic parental virus: pathogenesis of infection in macaques. J. Virol. 66:1992;3550-3556.
77. Sinclair E., Barbosa P., Feinberg M. B. The nef gene products of both simian and human immunodeficiency viruses enhance infectivity and are functionally interchangeable. J. Virol. 71:1997;3641-3651.
78. Smith B. L., Krushelnycky B. W., Mochly-Rosen D., Berg P. The HIV Nef protein associates with protein kinase C theta. J. Biol. Chem. 271:1996;16753-16757.
79. Takahashi K., Wesselingh S. L., Griffin D. E., McArthur J. C., Johnson R. T., Glass J. D. Localization of HIV-1 human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann. Neurol. 39:1996;705-711.
80. Tornatore C., Chandra R., Berger J. R., Major E. O. HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology. 44:1994;481-487.
81. Yu G., Felsted R. L. Effect of myristoylation on p27nef subcellular distribution and suppression of HIV-LTR transcription. Virology. 187:1992;46-55.
82. Zink M. C., Martin A. A., Mankowski J. L., Craig L., Munoz A., Didier P., Carter D. L., Murphy-Corb M., Clements J. E. Pathogenesis of SIV encephalitis: selection and replication of neurovirulent SIV. Am. J. Pathol. 151:1997;793-803.